Carcinoma, Hepatocellular Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
Recruiting
  • Carcinoma, Hepatocellular
  • +3 more
  • Duarte, California
  • +12 more
2022-04-07
Apr 7, 2022
T
Recruiting
  • Carcinoma, Hepatocellular
  • Metastatic Liver Cancer
  • BioTraceIO Lite
  • Phoenix, Arizona
  • +5 more
2022-03-23
Mar 23, 2022
E
Active, not recruiting
  • Carcinoma, Hepatocellular
  • +3 more
  • Microwave ablation
  • Seoul, Korea, Republic of
    Samsung Medical Center
2022-03-21
Mar 21, 2022
G
Recruiting
  • Carcinoma, Hepatocellular
  • Cirrhosis, Liver
    • Los Angeles, California
    • +19 more
    2022-03-14
    Mar 14, 2022
    E
    Active, not recruiting
    • Liver Neoplasms
    • Carcinoma, Hepatocellular
    • Non-interventional
    • Cheonan, Chungcheongnam-do, Korea, Republic of
    • +41 more
    2022-03-14
    Mar 14, 2022
    C
    Recruiting
    • Carcinoma, Hepatocellular
    • embolization
    • Hong Kong, Hong Kong
      Department of Imaging and Interventional Radiology, Prince of Wa
    2022-03-10
    Mar 10, 2022
    B
    Active, not recruiting
    • Carcinoma, Hepatocellular
    • Los Angeles, California
    • +6 more
    2022-03-10
    Mar 10, 2022
    C
    Recruiting
    • Carcinoma, Hepatocellular
    • Ablative chemoembolization (ACE)
    • Hong Kong, Hong Kong
      Department of Imaging and Interventional Radiology, Prince of Wa
    2022-03-10
    Mar 10, 2022
    E
    Completed
    • Carcinoma, Hepatocellular
    • +3 more
    • Osaka, Japan
    • +1 more
    2022-03-07
    Mar 7, 2022
    M
    Active, not recruiting
    • Hepatitis B
    • +2 more
      • Rochester, Minnesota
        Mayo Clinic
      2022-03-04
      Mar 4, 2022
      M
      Completed
      • Carcinoma, Hepatocellular
      • Tepotinib 300 mg
      • +4 more
      • Beijing, Beijing, China
      • +42 more
      2021-12-16
      Dec 16, 2021
      E
      Recruiting
      • Carcinoma, Hepatocellular
      • Bangalore, Karnataka, India
      • +8 more
      2022-02-07
      Feb 7, 2022
      C
      Recruiting
      • HER2-positive
      • +30 more
      • CT-0508
      • Duarte, California
      • +4 more
      2022-02-01
      Feb 1, 2022
      G
      Recruiting
      • Carcinoma, Hepatocellular
      • +2 more
      • Hepatic Resection
      • Radiofrequency Ablation
      • Nanning, Guangxi, China
        Department of Hepatobilliary Surgery, Affiliated Tumor of Guangx
      2022-01-14
      Jan 14, 2022
      U
      Recruiting
      • Carcinoma, Hepatocellular
      • Idarubicin and Lipiodol
      • Angers, France
      • +3 more
      2021-12-24
      Dec 24, 2021